to BioTechniques free email alert service to receive content updates.
Proteomics
BLItz platform for label-free protein analysis
ForteBio's BLItz platform for cost-efficient label-free analyses of proteins using small sample volumes.
BLItz is small–taking up less surface area than a tablet personal computer–so it can fit easily in an individual scientist's workspace and is simple to use. It requires only four microliters of sample, which is 15 to 20 times less volume than needed for traditional, SPR-based label-free assays or microplate-based ELISA assays. Additionally, its Dip and Read assays utilize disposable, ready-to-use biosensors to uniquely provide results in seconds to minutes. BLItz utilizes the same BioLayer Interferometry (BLI) technology that powers ForteBio's flagship Octet instrumentation platform, which enables real-time kinetics, affinity and quantitation measurements in high-throughput applications, with unprecedented ease of use and cost-efficiency. The new BLItz system is designed for any researcher working with proteins, particularly those who analyze column fractions, monitor protein expression, perform reagent QC, identify mechanism of action and signaling, and run protein engineering studies.
 
This Product is made by:

ForteBio is a life science company that provides analytical systems to accelerate biotherapeutic drug discovery and development. These systems enable real-time, label-free analysis of biomolecular interactions, providing information on affinity, kinetics and concentration. ForteBio’s analytical capabilities enable significantly easier, faster and better characterization of drug candidates, thus providing greater value in drug development applications where existing methods have limitations in throughput, performance and cost. The company is headquartered in Menlo Park, California, with wholly owned subsidiaries in London and Shanghai.